SCHEMBL13638807

SCHEMBL13638807

COCCN(C)Cc1ccc(N=O)c(C(=O)Nc2cccnc2)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.47
HPGD P15428 2/20 0.47
TDP1 Q9NUW8 1/20 0.47
SMN1; SMN2 Q16637 3/20 0.44
KDM4E B2RXH2 2/20 0.44
NPC1 O15118 2/20 0.44
MAPT P10636 2/20 0.44
RAB9A P51151 2/20 0.44
TSHR P16473 1/20 0.44
GAA P10253 1/20 0.44
TRPV1 Q8NER1 2/20 0.43
LRRK2 Q5S007 5/20 0.43
HIF1A Q16665 1/20 0.43
EPAS1 Q99814 1/20 0.43
POLB P06746 1/20 0.43
NAMPT P43490 1/20 0.43
MCL1 Q07820 1/20 0.42
CYP11B1 P15538 1/20 0.42
CYP11B2 P19099 1/20 0.42
SGMS2 Q8NHU3 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13162040 0.87 BRAF (0.54) ALDH1A1HPGDTDP1SMN1; SMN2KDM4E
SCHEMBL13163949 0.86 CCNE2 (0.49) ALDH1A1HPGDTDP1SMN1; SMN2KDM4E
SCHEMBL13162750 0.83 SMN1; SMN2 (0.46) ALDH1A1HPGDTDP1SMN1; SMN2KDM4E
SCHEMBL13638804 0.77 RAB9A (0.62) ALDH1A1TDP1SMN1; SMN2KDM4ENPC1
SCHEMBL13638900 0.77 BRAF (0.54) TDP1NPC1MAPTTRPV1POLB
SCHEMBL13634247 0.73 SMN1; SMN2 (0.48) ALDH1A1SMN1; SMN2MAPTTRPV1HIF1A
SCHEMBL13638862 0.73 NTRK1 (0.39) NPC1RAB9A
SCHEMBL13638854 0.71 RAB9A (0.62) ALDH1A1TDP1SMN1; SMN2KDM4ENPC1
SCHEMBL13638956 0.71 CYP11B2 (0.62) ALDH1A1HPGDKDM4ELRRK2HIF1A
SCHEMBL13638850 0.69 KMT2A (0.42) ALDH1A1TRPV1LRRK2NAMPTCYP11B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8304547-B2 Azolecarboxamide compound or salt thereof ASTELLAS PHARMA INC. (JP) 2012-11-06 US disclosed